Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | HGFAC | Q04756 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30744224 | 1.00 | ELANE (0.55) | ELANEKDM4EKMT2ATDP1MEN1 | |
| SCHEMBL27322408 | 1.00 | ELANE (0.55) | ELANEKDM4EKMT2ATDP1MEN1 | |
| SCHEMBL11961792 | 0.94 | ELANE (0.56) | ELANEKDM4EKMT2ATDP1MEN1 | |
| SCHEMBL30337451 | 0.90 | KDM4E (0.60) | ELANEKDM4EKMT2ATDP1MEN1 | |
| SCHEMBL1319590 | 0.90 | KDM4E (0.60) | ELANEKDM4EKMT2ATDP1MEN1 | |
| Hydrochloric Acid SCHEMBL1318956 | 0.88 | KDM4E (0.58) | ELANEKDM4EKMT2ATDP1MEN1 | |
| SCHEMBL13409755 | 0.88 | ELANE (0.64) | ELANEKMT2ATDP1MEN1MAPT | |
| SCHEMBL11963929 | 0.87 | KDM4E (0.57) | ELANEKDM4EKMT2ATDP1MEN1 | |
| SCHEMBL12376709 | 0.86 | ELANE (0.56) | ELANEKDM4EKMT2ATDP1MEN1 | |
| SCHEMBL23641002 | 0.85 | ELANE (0.50) | ELANEKMT2ATDP1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4538305-A1 | ATROPISOMER OF 1,1`-BINAPHTHYL DERIVATIVE, POLYMERIZABLE LIQUID CRYSTAL COMPOUND, OPTICAL FILM, IMPAGE DISPLAY DEVICE, AND EYEWEAR | Nippon Kayaku Kabushiki Kaisha (JP) | 2025-04-16 | — | — | EP | disclosed |
| US-20250101307-A1 | ATROPISOMER OF 1,1'-BINAPHTHYL DERIVATIVE, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL FILM, IMAGE DISPLAY DEVICE, AND EYEWEAR | NIPPON KAYAKU KK (JP) | 2025-03-27 | — | — | US | disclosed |
| CN-119301164-A | Atropisomers of 1,1' -binaphthyl derivatives, polymerizable liquid crystal compositions, optical films, image display devices and glasses | 日本化药株式会社 | 2025-01-10 | — | — | CN | disclosed |
| WO-2023243408-A1 | ATROPISOMER OF 1,1'-BINAPHTHYL DERIVATIVE, POLYMERIZABLE LIQUID CRYSTAL COMPOUND, OPTICAL FILM, IMPAGE DISPLAY DEVICE, AND EYEWEAR | 日本化薬株式会社 | 2023-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250101307-A1 | ATROPISOMER OF 1,1'-BINAPHTHYL DERIVATIVE, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL FILM, IMAGE DISPLAY DEVICE, AND EYEWEAR | ACVRL1, AMY1A, PARL | ELANE 3411/4885KDM4E 4418/4885KMT2A 4113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.